Reply: Co-occurrence of MYC amplification and TP53 mutations in human cancer

Mark D M Leiserson^{1

2}, Fabio Vandin^{1

2

3}, Hsin-Ta Wu^{1

2}, Benjamin J Raphael^{1

2}

Affiliations

¹ Department of Computer Science, Brown University, Providence, Rhode Island, USA.
² Center for Computational Molecular Biology, Brown University, Providence, Rhode Island, USA.
³ Department of Information Engineering, University of Padova, Padova, Italy.

Comment

Mark D M Leiserson et al. Nat Genet. 2016 Feb.

. 2016 Feb;48(2):106-8.

doi: 10.1038/ng.3491.

Mark D M Leiserson^{1

2}, Fabio Vandin^{1

2

3}, Hsin-Ta Wu^{1

2}, Benjamin J Raphael^{1

2}

¹ Department of Computer Science, Brown University, Providence, Rhode Island, USA.
² Center for Computational Molecular Biology, Brown University, Providence, Rhode Island, USA.
³ Department of Information Engineering, University of Padova, Padova, Italy.

No abstract available

Comment on

Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
Leiserson MD, Vandin F, Wu HT, Dobson JR, Eldridge JV, Thomas JL, Papoutsaki A, Kim Y, Niu B, McLellan M, Lawrence MS, Gonzalez-Perez A, Tamborero D, Cheng Y, Ryslik GA, Lopez-Bigas N, Getz G, Ding L, Raphael BJ. Leiserson MD, et al. Nat Genet. 2015 Feb;47(2):106-14. doi: 10.1038/ng.3168. Epub 2014 Dec 15. Nat Genet. 2015. PMID: 25501392 Free PMC article.
Co-occurrence of MYC amplification and TP53 mutations in human cancer.
Ulz P, Heitzer E, Speicher MR. Ulz P, et al. Nat Genet. 2016 Feb;48(2):104-6. doi: 10.1038/ng.3468. Nat Genet. 2016. PMID: 26813759 No abstract available.